SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability

Convalescent plasma (CP) has been in use for the treatment of numerous infectious diseases for more than a century, recently also for coronavirus disease 2019 (COVID-19). A major challenge for this treatment is identifying suitable donors with sufficient levels of functional antibodies and to determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Laner-Plamberger, Sandra, Lindlbauer, Nadja, Weidner, Lisa, Gänsdorfer, Simon, Weseslindtner, Lukas, Held, Nina, Lauth, Wanda, Zimmermann, Georg, Kern, Jan Marco, Föttinger, Fabian, Ombres, Laura, Jungbauer, Christof, Rohde, Eva, Grabmer, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689947/
https://www.ncbi.nlm.nih.gov/pubmed/36359411
http://dx.doi.org/10.3390/diagnostics12112567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689947/
https://www.ncbi.nlm.nih.gov/pubmed/36359411
http://dx.doi.org/10.3390/diagnostics12112567

Ejemplares similares